Most semaglutide patients find they need 2030% fewer calories overall while still maintaining muscle mass, because the medication preserves lean tissue better than calorie restriction alone
Interpretation should always occur with a qualified healthcare provider
Who Should Consider Extended or Alternative GLP-1 Therapy Patients with metabolic syndrome, type 2 diabetes, significant baseline insulin resistance, or family history of obesity may benefit from discussing extended GLP-1 therapy with their provider
And that is just the resting metabolic rate change, before factoring in the other hormonal disruptions happening simultaneously
Slow eating, smaller frequent meals, and thorough chewing especially when synchronized with natural daylight hours enhance GLP-1 signaling and glucose regulation (PMC)
The contamination risk is real and the dosing accuracy is impossible to guarantee